Logo image of CELC

CELCUITY INC (CELC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CELC - US15102K1007 - Common Stock

102.35 USD
+1.21 (+1.2%)
Last: 12/23/2025, 4:30:00 PM
102.35 USD
0 (0%)
After Hours: 12/23/2025, 4:30:00 PM
Fundamental Rating

2

Taking everything into account, CELC scores 2 out of 10 in our fundamental rating. CELC was compared to 530 industry peers in the Biotechnology industry. The financial health of CELC is average, but there are quite some concerns on its profitability. CELC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CELC had negative earnings in the past year.
In the past year CELC has reported a negative cash flow from operations.
CELC had negative earnings in each of the past 5 years.
In the past 5 years CELC always reported negative operating cash flow.
CELC Yearly Net Income VS EBIT VS OCF VS FCFCELC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

CELC has a better Return On Assets (-34.19%) than 63.40% of its industry peers.
With a Return On Equity value of -139.12%, CELC is not doing good in the industry: 63.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -34.19%
ROE -139.12%
ROIC N/A
ROA(3y)-33.98%
ROA(5y)-41.85%
ROE(3y)-57.49%
ROE(5y)-59.3%
ROIC(3y)N/A
ROIC(5y)N/A
CELC Yearly ROA, ROE, ROICCELC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

CELC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CELC Yearly Profit, Operating, Gross MarginsCELC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

CELC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CELC has been increased compared to 5 years ago.
CELC has a worse debt/assets ratio than last year.
CELC Yearly Shares OutstandingCELC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CELC Yearly Total Debt VS Total AssetsCELC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

CELC has an Altman-Z score of 6.65. This indicates that CELC is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 6.65, CELC is doing good in the industry, outperforming 75.47% of the companies in the same industry.
A Debt/Equity ratio of 2.74 is on the high side and indicates that CELC has dependencies on debt financing.
CELC has a worse Debt to Equity ratio (2.74) than 81.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.74
Debt/FCF N/A
Altman-Z 6.65
ROIC/WACCN/A
WACCN/A
CELC Yearly LT Debt VS Equity VS FCFCELC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

CELC has a Current Ratio of 12.26. This indicates that CELC is financially healthy and has no problem in meeting its short term obligations.
CELC's Current ratio of 12.26 is amongst the best of the industry. CELC outperforms 87.36% of its industry peers.
A Quick Ratio of 12.26 indicates that CELC has no problem at all paying its short term obligations.
CELC has a Quick ratio of 12.26. This is amongst the best in the industry. CELC outperforms 87.36% of its industry peers.
Industry RankSector Rank
Current Ratio 12.26
Quick Ratio 12.26
CELC Yearly Current Assets VS Current LiabilitesCELC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CELC have decreased strongly by -40.61% in the last year.
EPS 1Y (TTM)-40.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CELC will show a very strong growth in Earnings Per Share. The EPS will grow by 36.97% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-35.7%
EPS Next 2Y-21.7%
EPS Next 3Y16.29%
EPS Next 5Y36.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CELC Yearly Revenue VS EstimatesCELC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
CELC Yearly EPS VS EstimatesCELC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CELC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CELC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CELC Price Earnings VS Forward Price EarningsCELC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CELC Per share dataCELC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

CELC's earnings are expected to grow with 16.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.7%
EPS Next 3Y16.29%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CELC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CELCUITY INC

NASDAQ:CELC (12/23/2025, 4:30:00 PM)

After market: 102.35 0 (0%)

102.35

+1.21 (+1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-30 2026-03-30/amc
Inst Owners78.61%
Inst Owner Change22.74%
Ins Owners10.32%
Ins Owner Change3.72%
Market Cap4.74B
Revenue(TTM)N/A
Net Income(TTM)-162.72M
Analysts86.25
Price Target112.71 (10.12%)
Short Float %19.45%
Short Ratio6.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.36%
Min EPS beat(2)-15.3%
Max EPS beat(2)10.59%
EPS beat(4)2
Avg EPS beat(4)-5.04%
Min EPS beat(4)-17.61%
Max EPS beat(4)10.59%
EPS beat(8)5
Avg EPS beat(8)1.13%
EPS beat(12)5
Avg EPS beat(12)-6.44%
EPS beat(16)5
Avg EPS beat(16)-9.26%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.4%
PT rev (3m)59.16%
EPS NQ rev (1m)4.11%
EPS NQ rev (3m)0.09%
EPS NY rev (1m)1.24%
EPS NY rev (3m)0.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 40.49
P/tB 40.49
EV/EBITDA N/A
EPS(TTM)-3.67
EYN/A
EPS(NY)-4.16
Fwd EYN/A
FCF(TTM)-3.12
FCFYN/A
OCF(TTM)-3.12
OCFYN/A
SpS0
BVpS2.53
TBVpS2.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.19%
ROE -139.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-33.98%
ROA(5y)-41.85%
ROE(3y)-57.49%
ROE(5y)-59.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.74
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 155.63%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.26
Quick Ratio 12.26
Altman-Z 6.65
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)112.26%
Cap/Depr(5y)77.3%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.43%
EPS Next Y-35.7%
EPS Next 2Y-21.7%
EPS Next 3Y16.29%
EPS Next 5Y36.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-55.17%
EBIT Next 3Y5.75%
EBIT Next 5YN/A
FCF growth 1Y-221.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-222.49%
OCF growth 3YN/A
OCF growth 5YN/A

CELCUITY INC / CELC FAQ

What is the ChartMill fundamental rating of CELCUITY INC (CELC) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CELC.


What is the valuation status for CELC stock?

ChartMill assigns a valuation rating of 0 / 10 to CELCUITY INC (CELC). This can be considered as Overvalued.


Can you provide the profitability details for CELCUITY INC?

CELCUITY INC (CELC) has a profitability rating of 1 / 10.